AssayIndex

SGN-2507-U1475

SS-31 (Elamipretide) · 20 mg declared · Sangon Biotech (Shanghai) Co., Ltd. · manufactured 11 Jul 2025

CHARACTERISED
Lot code
SGN-2507-U1475
Supplier
SGN — Sangon Biotech (Shanghai) Co., Ltd.
Compound
SS-31 (Elamipretide)
Compound class
Metabolic and mitochondrial peptides
Declared label claim
20mg
Manufacture date
11 Jul 2025
Index quarter
2025-Q4
Independent assays
4
Laboratories involved
Janoshik
Provenance mix
Buyer-sourced ×1 · Supplier-supplied ×3
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 4
Median purity 97.07% n=4
Spread (max − min) 0.59pp n=4
Standard deviation 0.282pp n=4
96.597.197.798.399.099.6100.2This lot (SGN-2507-U1475)This lot (SGN-2507-U1475): Q1 96.86, median 97.07, Q3 97.28, n=4n=4All SS-31 (Elamipretide)All SS-31 (Elamipretide): Q1 98.57, median 99.42, Q3 99.93, n=97n=97 Purity (% area)
Figure 1. This lot's independent purity results against the whole SS-31 (Elamipretide) record set in the index. The vertical line is the index acceptance specification for the metabolic and mitochondrial peptides class, 98.5 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 4

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020831SGN-2507-U1475Janoshik2025-Q497.364.36Supplier-supplied1FAIL
AX-2025-020832SGN-2507-U1475Janoshik2025-Q496.893.98104.4Supplier-supplied0FAIL
AX-2025-020833SGN-2507-U1475Janoshik2025-Q496.774.18103.7Buyer-sourced0FAIL
AX-2025-020834SGN-2507-U1475Janoshik2025-Q497.254.5290.9Supplier-supplied1FAIL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik497.36, 96.89, 96.77, 97.2597.0730min+0.0097.07

A single laboratory assayed this lot, so it contributes no paired comparison and the bias-adjusted column is a subtraction rather than a measurement.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)97.3797.36divergence +0.30 pp vs batch median
Total impurities (% area)2.632.64
Largest single impurity (% area)not stated1.54
Water (%)3.94.36
Counter-ion (%)not stated5.51
Peptide content (%w/w)not statednot determined
Endotoxin (EU/mg)not stated1.48
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
C-terminal free acid (+1 Da)4 / 41.160.68–1.89
des-Dmt (−193 Da)4 / 41.130.49–1.88
[D-Arg1]-epimer4 / 40.240.15–0.38
acetyl adduct (+42 Da)4 / 40.290.25–0.36
Section 7

What this rollup does not establish